NONOF News and Press, Novo-Nordisk A/S From 03/07/24

2024-03-07 13:05:47 ET Summary Novo Nordisk had a strong performance in 2023, driven by a significant increase in obesity care sales and market leadership in the global diabetes market. The company plans to invest heavily in expanding its manufacturing base, with discussions of am...

2024-03-07 09:33:18 ET More on Labcorp Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings Call Presentation Laboratory Corporation of America Q4 2023 Earnings Previe...

2024-03-07 06:43:36 ET More on Cigna Cigna: Trimming The Fat And Staying Focused Cigna: Big Buybacks And Total Return Potential The Cigna Group (CI) Q4 2023 Earnings Call Transcript Dividend Roundup: Southwest Airlines, Cigna, Deere, Gap, and more Pha...

2024-03-05 13:02:26 ET More on Eli Lilly Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly price target upped at UBS on GLP...

2024-02-23 12:31:39 ET Summary Prothena Corporation plc has an update coming on the phase 1 study using PRX012 for the treatment of patients with Alzheimer's Disease, expected in 2024. Company is already in the process of exploring the use of PRX012 for the treatment of patients w...

2024-02-23 05:15:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. The Global Growth Composite Portfolio outperformed the MSCI ACWI Index for the fourth quarter and t...

2024-02-22 21:01:24 ET Summary Novo Nordisk had a near perfect FY23. Fundamentally, FY24 should look quite similar. In reviewing FY23 results and commentary, we discuss key points like SELECT outcomes; CagriSema progress; and expansion into cardiovascular disease. Though expen...

2024-02-21 11:26:20 ET More on Ventyx Biosciences Ventyx: Too Risky Right Now After Some Poor Data Seeking Alpha’s Quant Rating on Ventyx Biosciences Historical earnings data for Ventyx Biosciences Financial information for Ventyx Biosciences ...

2024-02-20 15:45:00 ET Summary Eli Lilly's stock has seen a parabolic rise, with recent gains driven by retail buying, a surge in call option demand, and short covering, taking valuations to extreme levels. The stock is trading at 83x earnings, which is 4.2x the average of the res...

2024-02-20 11:00:28 ET Summary Healthcare stocks have seen a better 2024 so far this year than the entire 2023 and 2022 years combined. If you go back 2 calendar years, the broad-based Health Care Select Sector SPDR® Fund ETF was still down slightly on a total-return basis. B...